Targeted Brain Circuit Disruption Reduces Depression-Like Behavior in Rats and Reveals Sex-Based Differences in Antidepressant Response

Key Takeaways:

A brain circuit tied to stress shows antidepressant-like effects when disrupted in rats.
Male and female rats responded differently to antidepressants and brain changes.
Sex-specific brain activity may influence how depression is treated.
Findings are early-stage and based on animal research, not humans.

Depression , a debilitating mental health condition, affects approximately 280 million people globally and is about 50% more common among women than among men (World Health Organization, 2023). Current treatments, such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants, often require weeks to take effect and fail to help up to 30% of patients (Trivedi et al., 2006). Understanding the brain’s stress and mood circuits could pave the way for more effective therapies. A recent study by Kafetzopoulos et al. (2025) investigates the role of the nucleus reuniens (RE), a thalamic region linking the prefrontal cortex (PFC) and hippocampus, in depressive-like behaviors in rats, highlighting sex-specific responses to stress and antidepressants. This article examines the study’s methods, findings, and limitations, and considers its implications for human depression treatment, emphasizing the challenges of translating rodent research to clinical practice.

Study Methods, Findings, and Discussion

Study Design and Methodology

The study, conducted by researchers at the National and Kapodistrian University of Athens, used male and female Wistar rats to explore the nucleus reuniens’ role in stress-related behaviors (Kafetzopoulos et al., 2025). The RE, a small thalamic structure, facilitates communication between the PFC, which governs decision-making and emotion regulation, and the hippocampus, critical for memory and stress processing (Vertes et al., 2007). The researchers employed a controlled experimental design:

Intervention: Rats underwent either a surgical lesion of the RE or a sham (control) operation to assess the RE’s impact on behavior.
Treatment: Post-surgery, rats received one of three treatments: sertraline (10 mg/kg, an SSRI), clomipramine (10 mg/kg, a tricyclic antidepressant), or a vehicle (placebo).
Behavioral Assessment: The Forced Swim Test (FST) was used to measure depressive-like behaviors. In the FST, increased immobility reflects despair-like behavior, while increased swimming or climbing indicates active coping, interpreted as an antidepressant-like effect (Porsolt et al., 1977).
Neural Activity Measurement: c-Fos expression, a marker of neuronal activation, was measured in the PFC, hippocampus (CA1 region), and RE to assess circuit-level responses.

This design allowed the researchers to compare behavioral and neural outcomes across sexes, treatments, and surgical conditions, providing a comprehensive view of the RE’s role and sex-specific antidepressant effects.

Key Findings

The study yielded several critical findings (Kafetzopoulos et al., 2025):

RE Lesion Effects: Lesioning the RE reduced immobility and increased swimming in the FST for both male and female rats, suggesting an antidepressant-like effect. This indicates that the RE plays a pivotal role in modulating stress responses, potentially by disrupting maladaptive circuit activity between the PFC and hippocampus.
Antidepressant Responses:
- Sertraline: Increased swimming and head-shaking behavior (linked to serotonin activity) in both sexes, suggesting a consistent serotonergic effect across male and female rats.
- Clomipramine: Increased climbing behavior, with more pronounced effects in males, indicating that this tricyclic antidepressant, which targets both serotonin and norepinephrine, may have sex-specific mechanisms.
Sex Differences in Neural Activity:
- Female rats exhibited higher baseline c-Fos expression in the PFC and CA1 region of the hippocampus compared to males, suggesting greater neural activity in these regions, possibly influenced by hormonal factors like estrogen (Bangasser & Valentino, 2014).
- Clomipramine reduced PFC and CA1 activity in females but not males, highlighting a sex-specific neural response to this drug.
- The RE showed lower baseline activity in females than males, and clomipramine further reduced RE activity in males compared to their vehicle-treated controls, suggesting distinct circuit dynamics.

Discussion of Findings

The study’s results underscore the RE’s critical role in stress-related behaviors. By lesioning the RE, researchers disrupted the PFC–hippocampus circuit, leading to reduced immobility in the FST, a behavior akin to the effects of antidepressants (Kafetzopoulos et al., 2025). This suggests that the RE may act as a relay hub, amplifying stress signals that contribute to depressive-like states. The consistent antidepressant-like effect of RE lesions in both sexes contrasts with the sex-specific responses to pharmacological treatments, particularly clomipramine, which affected males more prominently in climbing behavior and RE activity. This aligns with prior evidence that antidepressants targeting multiple neurotransmitters (e.g., serotonin and norepinephrine) can produce varied effects across sexes, possibly due to hormonal modulation of neural circuits (Bangasser & Valentino, 2014).

The c-Fos data provides deeper insight into sex differences. Higher baseline PFC and CA1 activity in females may reflect greater sensitivity to stress or hormonal influences, as ovarian hormones like estrogen are known to modulate stress responses in these regions (Drossopoulou et al., 2004). Clomipramine’s reduction of activity in female PFC and CA1, but not in males, suggests that females may rely more on these regions for stress processing, while males’ responses involve the RE more directly. The lower RE activity in females, especially with clomipramine, further highlights circuit-level differences that could inform sex-specific treatment strategies.

Limitations

The study has notable limitations that temper its implications:

FST as a Model: The FST is a widely used but simplified model that measures acute stress responses, not the chronic, multifaceted nature of human depression, which includes emotional, cognitive, and physiological symptoms (Nestler & Hyman, 2010). This limits its direct relevance to clinical depression.
Lesion-Based Approach: Surgically lesioning the RE is a research tool, not a viable human treatment, due to its invasiveness and ethical concerns (Kafetzopoulos et al., 2025).
Acute Focus: The study examined acute responses to stress and treatment, leaving questions about chronic stress models, which are more relevant to human depression, unanswered.
Translational Gap: Rodent brains differ significantly from human brains in structure and complexity, making direct extrapolation to human treatment challenging (Nestler & Hyman, 2010).

These limitations highlight the need for caution when interpreting the study’s findings for human applications, emphasizing the preliminary nature of the research.

FAQs

What is the nucleus reuniens?
It’s a small brain region in the thalamus that connects the prefrontal cortex and hippocampus, areas involved in emotion, memory, and stress regulation.

Why was this study conducted in rats?
Rats are widely used in neuroscience to model brain function and test antidepressant effects before human studies.

What does lesioning a brain area mean?
It means intentionally damaging a specific brain region to study its function—in this case, to see how the RE affects stress and depression-like behaviors.

What is the Forced Swim Test (FST)?
A behavioral test where rats are placed in water. Immobility suggests despair-like behavior; swimming or climbing indicates active coping.

Is the Forced Swim Test a reliable model for depression?
It’s widely used but limited. It captures acute stress responses, not the full range of symptoms seen in human depression.

What did the study find about the RE lesion?
Rats with RE lesions showed less immobility and more active behavior in the FST, similar to those treated with antidepressants.

How do sertraline and clomipramine work?
Sertraline is an SSRI that boosts serotonin. Clomipramine is a tricyclic that affects both serotonin and norepinephrine.

How did male and female rats respond differently to antidepressants?
Both drugs reduced depressive-like behavior, but clomipramine had stronger effects in males, especially in climbing behavior and brain activity.

What is c-Fos and why was it measured?
c-Fos is a protein that marks active neurons. Measuring it helps researchers see which brain areas responded during testing.

What brain regions were analyzed in the study?
The prefrontal cortex (PFC), hippocampus (CA1 region), and nucleus reuniens (RE).

Why did female rats show higher brain activity?
It may be due to estrogen, which increases neural excitability in stress-related brain regions.

Did clomipramine affect males and females differently?
Yes. It reduced activity in the PFC and hippocampus in females but had little effect on those areas in males.

Why is sex an important factor in depression research?
Men and women often differ in brain chemistry, hormone levels, and stress response, which can affect how antidepressants work.

Can these findings be applied to humans?
Not directly. The results offer insight but are based on animal models, not clinical trials.

Is damaging a brain region a real treatment option?
No. Lesioning is a research tool used in animal studies. It’s not safe or ethical in humans.

Was the brain circuit damage accidental or intentional?
It was intentional. Researchers used a targeted chemical lesion to study how disrupting the nucleus reuniens affects depression-like behavior.

Why did the researchers disrupt a brain region on purpose?
They wanted to understand the role of the nucleus reuniens in stress and mood by observing what happens when it’s no longer functioning.

What method was used to disrupt the brain circuit?
A chemical called NMDA was used to selectively damage the nucleus reuniens in a controlled, surgical procedure.

Is brain lesioning used in human depression treatment?
No. It’s a research technique used in animal studies to explore brain function, not a clinical therapy for people.

What did the intentional brain disruption reveal?
It showed that removing the nucleus reuniens reduced depression-like behavior in rats, similar to the effects of antidepressants.

Does this mean damaging brain regions could treat depression?
Not at all. The goal is to understand which brain circuits matter—not to promote damaging them as treatment.

Could this lead to non-invasive treatments in the future?
Potentially. Mapping key circuits may help guide therapies like brain stimulation or targeted medications down the line.

What are SSRIs and tricyclic antidepressants?
SSRIs (like sertraline) increase serotonin. Tricyclics (like clomipramine) affect multiple neurotransmitters and tend to have more side effects.

Why do antidepressants take weeks to work?
They slowly alter brain signaling and structure, which takes time to influence mood.

What makes this study different from past research?
It examined both sexes and looked at brain circuit responses, not just behavioral changes, giving a fuller picture of how antidepressants work.

What does the study suggest about personalized treatment?
That sex-specific brain differences could help explain why some drugs work better for certain people, pointing to the need for tailored approaches.

What are the limitations of this study?
It used rats, studied short-term effects, and relied on invasive methods. Human brains are more complex, so findings may not fully translate.

What role might estrogen play in depression?
Estrogen can affect brain activity and stress response, possibly making females more sensitive to certain antidepressants.

Could this lead to new treatments?
Possibly. Understanding how circuits like the RE work may help guide non-invasive therapies in the future, but it’s still early-stage.

Why is the hippocampus involved in depression?
It’s key for memory and stress regulation. Changes here are often seen in people with depression.

What’s the main takeaway for patients or clinicians?
Depression is complex and may require sex-specific approaches to treatment. This study supports further research in that direction.

Final Thoughts: Implications for Human Antidepressants

The study by Kafetzopoulos et al. (2025) advances our understanding of brain circuits in stress and antidepressant responses, particularly by highlighting sex differences, but it is not a turning point for human depression treatment. Conducted in rats, the findings cannot be directly applied to humans due to the FST’s limitations and the infeasibility of brain lesions as a therapy. The RE’s role as a stress-modulating hub is intriguing, but translating this to clinical practice—such as through non-invasive methods like transcranial magnetic stimulation—remains speculative and distant.

The emphasis on sex-specific neural responses is a key strength, given that women are diagnosed with depression twice as often as men (World Health Organization, 2020). The differential effects of clomipramine and sertraline suggest that antidepressants may need tailoring based on sex, potentially influenced by hormones like estrogen (Bangasser & Valentino, 2014). However, this study is not revolutionary; it builds incrementally on existing circuit-based research. It underscores the need for further studies in chronic stress models and human-relevant systems to bridge the translational gap. For now, it’s a valuable but preliminary contribution, not hype, pointing to the importance of personalized, sex-informed approaches in future antidepressant development.

References

Kafetzopoulos, V., Kokras, N., Katsaitis, F., Sousa, N., Leite-Almeida, H., Sotiropoulos, I., & Dalla, C. (2025). Prefrontal cortex–nucleus reuniens–hippocampus network exhibits sex-differentiated responses to stress and antidepressant treatment in rats. Psychopharmacology, 242(7), 1627–1639. https://doi.org/10.1007/s00213-024-06667-w

Bangasser, D. A., & Valentino, R. J. (2014). Sex differences in stress-related psychiatric disorders: Neurobiological perspectives. Frontiers in Neuroendocrinology, 35(3), 303–319. https://doi.org/10.1016/j.yfrne.2014.03.008

Nestler, E. J., & Hyman, S. E. (2010). Animal models of neuropsychiatric disorders. Nature Neuroscience, 13(10), 1161–1169. https://doi.org/10.1038/nn.2647

Porsolt, R. D., Le Pichon, M., & Jalfre, M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature, 266(5604), 730–732. https://doi.org/10.1038/266730a0

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., … & Fava, M. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163(1), 28–40. https://doi.org/10.1176/appi.ajp.163.1.28

Vertes, R. P., Hoover, W. B., Szigeti-Buck, K., & Leranth, C. (2007). Nucleus reuniens of the midline thalamus: Link between the medial prefrontal cortex and the hippocampus. Brain Research Bulletin, 71(6), 601–609. https://doi.org/10.1016/j.brainresbull.2006.12.002

World Health Organization. (2023). Depression fact sheet. https://www.who.int/news-room/fact-sheets/detail/depression

Drossopoulou, G., Antoniou, K., Kitraki, E., Papathanasiou, G., Papalexi, E., Dalla, C., & Papadopoulou-Daifoti, Z. (2004). Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience, 126(4), 849–857. https://doi.org/10.1016/j.neuroscience.2004.04.044